Search PubMedSearch

PubMed · 1644569

Long-range alpha detector.

Abstract

Historically, alpha-particle detectors have been limited by the very short range of alpha particles in air. This results in a number of problems inherent to alpha contamination detectors, such as relatively poor sensitivity, geometry limitations, and inefficient monitoring techniques. In this paper, we document tests of a new long-range alpha detector. The charges generated by the interaction of alpha particles with air can be transported over significant distances (several meters) in a moving current of air generated by a small fan. An ion chamber located in front of the fan measures the current carried by the moving ions and, hence, detects the alpha decays.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D W MacArthur, K S Allander, J A Bounds, K B Butterfield, J L McAtee. 1992. Long-range alpha detector.. https://doi.org/10.1097/00004032-199209000-00008

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Induction of sister chromatid exchanges by extremely low doses of alpha-particles.

The induction of sister chromatid exchanges (SCE) was examined in Chinese hamster ovary cells irradiated in the G1 phase of the cell cycle with alpha-particles from a plutonium-238 source. A significant increase in the frequency of SCE occurred with doses as low as 0.31 mGy (31 millirads). Although 30% of the cells showed an increased frequency of SCE at this dose, less than 1% of cell nuclei were actually traversed by an alpha-particle. A dose of approximately 2.0 Gy was necessary to produce a similar increase in SCE by X-rays. These results indicate that genetic damage may be induced by low doses of alpha-radiation in cell nuclei not actually traversed by an alpha-particle. This phenomenon may have important implications in the estimation of risks of such exposures.

Alpha Particles

Effective alpha-particle-mediated radioimmunotherapy of murine leukemia.

The specificity, toxicity, and efficacy of alpha-particle-mediated radioimmunotherapy of murine erythroleukemia was assessed by use of tumor-specific monoclonal antibody 103A labeled with 212Bi. Forty % of the injected dose/g tissue targeted to neoplastic spleens within 1 h after i.v. injection. When 212Bi-103A was injected on day 13 of disease, a dose-dependent response was achieved, as measured by a reduction in splenomegaly and absence of liver metastasis. Mice treated with 212Bi-103A on day 8 of disease showed no histological evidence of erythroleukemia on day 22 and survived significantly longer (median, 118 days) than mice treated with 212Bi-control IgG (78 days) or untreated mice (63 days), indicating successful specific radioimmunotherapy.

Alpha Particles